HbA1c

Related by string. HbA 1c . HbA1C . Hb A1C . HbA 1C . Hb A1c * * baseline HbA1c . hemoglobin A1c HbA1c . Hemoglobin A1c HbA1c . hemoglobin A1C HbA1C . HbA1c levels . glycosylated hemoglobin HbA1c . HbA1C levels . glycated hemoglobin HbA1c . mean baseline HbA1c *

Related by context. All words. (Click for frequent words.) 80 A1C 80 HbA1c levels 79 A1c 76 HbA1C 75 HbA 1c 74 A1C levels 72 glycated hemoglobin 72 Hb A1C 72 glycosylated hemoglobin 72 hemoglobin A1c 72 hemoglobin A1C 71 hemoglobin A1c HbA1c 71 fasting plasma glucose 70 serum phosphorus 70 fasting blood glucose 70 baseline HbA1c 69 mg dL 69 A1c levels 68 hemoglobin A1c levels 68 LDL C 68 glycosylated hemoglobin HbA1c 67 glycated hemoglobin HbA1c 67 glycated hemoglobin levels 67 serum potassium 67 fasting glucose 67 HbA 1c levels 66 fasting plasma glucose FPG 66 HbA1C levels 66 insulin glargine 66 sUA 65 blood glucose levels 65 NPH insulin 65 mmHg 64 lispro 64 LVEF 64 glomerular filtration rate 64 blood glucose 64 eGFR 64 microalbuminuria 64 serum phosphate 63 mg dl 63 lumbar spine BMD 63 serum urate 63 mmol l 63 glycemia 63 HOMA IR 63 antihypertensive medications 63 serum uric acid 63 OGTT 63 mmol L 62 pioglitazone 62 insulin detemir 62 NT proBNP 62 fasting glucose levels 62 mm Hg 62 glimepiride 62 Hb 62 serum creatinine levels 62 g dL 62 MADRS score 62 hypertensive patients 61 glycosylated hemoglobin levels 61 systolic BP 61 mmol L. 61 creatinine 61 serum phosphate levels 61 -#.# mg dL [002] 61 Hemoglobin A1c 61 blood Phe 61 sitagliptin 61 ng mL 61 platelet reactivity 61 serum creatinine 61 fasting insulin 61 HbA 1C 61 creatinine levels 61 glycemic control 61 #mmHg [002] 61 Hb A1c 61 HCV RNA 61 alanine aminotransferase ALT 61 hsCRP 60 viral load 60 mL/min/#.# m 2 60 plasma HCV RNA 60 #/#mmHg 60 undetectable HCV RNA 60 oral glucose tolerance 60 #.#/#.# mmHg [001] 60 mean baseline HbA1c 60 systolic blood pressure 60 hypertensives 60 HBeAg seroconversion 60 undetectable viral load 60 sweat chloride 60 PASI scores 60 hs CRP 60 postprandial glucose 60 serum IGF 60 peginterferon alfa 2a 60 virologic response 60 creatinine ratio 60 ACR# response 60 serum calcium 60 albumin excretion 60 atherogenic dyslipidemia 59 cystatin C 59 glargine 59 complete cytogenetic response 59 rimonabant #mg 59 iPTH 59 creatinine clearance 59 Lantus ® 59 total cholesterol LDL 59 #mg/dL [001] 59 statistical significance p 59 hemoglobin concentrations 59 blood Phe levels 59 urine albumin 59 retinal thickness 59 nmol L 59 BENICAR HCT 59 neutrophil counts 59 apolipoprotein B 59 candesartan 59 HDL C 59 metformin 59 IU mL 59 CLA supplementation 59 Hb levels 59 HAQ DI 59 irbesartan 59 PSADT 59 virologic failure 59 triglyceride levels 59 blood sugar 59 detemir 59 serum sodium 59 lung function 59 log# copies mL 59 platelet inhibition 59 insulin lispro 59 serum triglycerides 59 PSA nadir 59 DAS# [002] 59 pg mL 59 ng ml 59 FEV1 59 lipid levels 59 pCR 59 hydroxyvitamin D levels 59 triglyceride concentrations 59 estimated GFR 59 UACR 59 EDSS score 59 baseline A1C 59 LDL 59 QTcF 59 IPSS 59 valsartan 58 #.#mmol L [001] 58 μmol L 58 systolic 58 LDL cholesterol 58 mU L 58 sUA levels 58 plasma glucose levels 58 elevated LDL cholesterol 58 biphasic insulin aspart 58 LDL cholesterol levels 58 #mg/dL [002] 58 mEq L 58 asymptomatic carotid stenosis 58 Fasting glucose 58 BENICAR 58 HIV RNA 58 hemoglobin levels 58 sustained virologic response 58 #.#mg/dL 58 Crohn Disease Activity 58 log# IU mL 58 serum calcium levels 58 lipid parameters 58 serum glucose 58 colesevelam HCl 58 proteinuria 58 nondiabetic patients 58 fosamprenavir 58 mmHg diastolic 58 #.#mmol L [002] 58 leukocyte count 58 serum triglyceride levels 58 oral antidiabetic medication 58 LANTUS R 58 serum testosterone 58 serum phosphorous 58 serum HCV RNA 58 diastolic BP 58 serum concentrations 58 serum HBV DNA 58 #mmHg [001] 58 gliclazide 58 certolizumab 58 troponin T 58 achieved statistical significance 58 tHcy 58 antihypertensive therapy 58 CDAI score 58 bezafibrate 58 NYHA functional class 58 hemoglobin concentration 58 median PFS 58 exhaled nitric oxide 58 advanced adenomas 58 Psoriasis Area 58 peginterferon 58 placebo p 58 glulisine 57 carotid intima media 57 HBV DNA levels 57 unfractionated heparin 57 intima media thickness 57 cardiovascular mortality 57 hsCRP levels 57 procalcitonin 57 HBV DNA 57 tiotropium 57 serum urate levels 57 mm Hg systolic 57 nonfasting triglyceride levels 57 XIENCE V PROMUS Stent 57 intact parathyroid hormone 57 OADs 57 allopurinol 57 salmeterol fluticasone propionate 57 alanine aminotransferase 57 NATRECOR R 57 glucose lowering 57 ng dL 57 dapagliflozin plus 57 thyroxine 57 Lucentis monotherapy 57 CCyR 57 complete cytogenetic 57 mg dose 57 T2DM 57 #mg/day [001] 57 metabolic parameters 57 peak VO2 57 tolvaptan 57 fructosamine 57 mmHg systolic 57 Score DAS# 57 serum vitamin D 57 Apidra ® 57 β blockers 57 urinary albumin 57 olmesartan 57 C reactive protein 57 binary restenosis 57 fasting triglyceride levels 57 copies mL 57 mean serum phosphorus 57 metformin sulfonylurea 57 sustained virological response 57 lipid profiles 57 nicardipine 57 CK MB 57 ATACAND 56 definite stent thrombosis 56 D dimer 56 #mg/dl 56 serum cholesterol 56 oxycodone CR 56 d dimer 56 arterial stiffness 56 LEXIVA r 56 tipranavir 56 Hemoglobin A1C 56 virological response 56 CDAI 56 vildagliptin 56 glucose 56 nonsignificant 56 exhaled NO 56 CrCl 56 LPV r 56 LDL Cholesterol 56 paricalcitol 56 NCEP ATP III 56 active comparator 56 homocysteine concentrations 56 statistically significant p = 56 ritonavir boosted 56 -#.# log# 56 chlorthalidone 56 metformin sulphonylurea 56 serum phosphorus levels 56 pramlintide 56 -#.# mg dL [001] 56 liraglutide 56 statistically significant p 56 CRESTOR #mg 56 virologic 56 K DOQI 56 fetuin 56 normotensive 56 oral allopurinol 56 placebo p = 56 serum bilirubin 56 rosuvastatin 56 diastolic blood pressure 56 ARB telmisartan 56 anticoagulation 56 pg ml 56 MMSE scores 56 calculated creatinine clearance 56 per deciliter mg 56 sunitinib 56 eplerenone 56 adalimumab 56 serum PSA 56 glomerular filtration 56 macroalbuminuria 56 Score IPSS 56 μg dL 56 serum CRP 56 ONGLYZA 56 mean baseline A1C 56 C Reactive Protein 56 Cmax 56 HCTZ 56 clinically meaningful 56 morphometric vertebral fractures 56 lactate dehydrogenase LDH 56 Pioglitazone 56 placebo 56 secondary efficacy endpoints 56 MDRD equation 56 nondiabetics 56 cholesterol LDL C 55 titrated glipizide 55 triglycerides 55 Victoza R 55 EDSS scores 55 statin monotherapy 55 plasma glucose 55 annualized relapse 55 primary efficacy endpoint 55 dose clopidogrel 55 benazepril 55 Prostate Specific Antigen PSA 55 albumin excretion rate 55 antihypertensive drugs 55 magnesium intake 55 microalbumin 55 aspartate aminotransferase AST 55 mcg kg 55 tirofiban 55 ejection fraction 55 pharmacokinetic PK profile 55 liver histology 55 oral antidiabetic drugs 55 HDL Cholesterol 55 #mg doses [002] 55 incontinence episodes 55 adiponectin levels 55 elevated blood glucose 55 inadequate glycemic 55 CD4 + cell 55 severe exacerbations 55 serum PTH 55 triglyceride 55 blood phenylalanine Phe 55 CK # plasma concentrations 55 mcg mL 55 hypoglycemic events 55 noninferiority 55 ACTOS 55 hypoglycemia 55 ejection fractions 55 oral antidiabetic medications 55 unfractionated heparin UFH 55 serum magnesium 55 Elitek 55 prostate specific antigen 55 HDRS 55 oral antidiabetes 55 microvascular complications 55 nelfinavir 55 atorvastatin #mg 55 undetectable viral 55 log# 55 MetS 55 CI -#.# 55 Engerix B 55 eNO 55 Montgomery Asberg Depression 55 hyperglycemia 55 sulfonylurea 55 fondaparinux 55 solifenacin 55 subclinical hypothyroidism 55 x ULN 55 isolated systolic hypertension 55 tipranavir r 55 chlorambucil 55 fluticasone salmeterol 55 serum lipid levels 55 impaired fasting glucose 55 thyroglobulin 55 reinfarction 55 log# reduction 55 clinically meaningful improvement 55 liver enzymes 55 cTnT levels 55 mg kg dose 55 diastolic blood pressures 55 VIAject ™ 55 pmol L 55 secondary endpoint 55 resistant hypertension 55 uric acid levels 55 triacylglycerol concentrations 55 macrovascular events 55 Negative Syndrome 55 severe hypoglycemia 55 bad cholesterol LDL 55 peginterferon alfa 2b 55 cardiovascular morbidity 55 IFN α 55 lipid lowering therapy 55 elevated creatinine 55 tocilizumab 55 aripiprazole 55 elevated uric acid 55 plasma leptin 55 glyburide 55 lopinavir r 55 poor metabolizers 55 corticosteroid dose 55 umol L 55 #.#ng/ml 55 atherogenic lipids 55 urate lowering therapy 55 6MWD 55 metformin monotherapy 55 adiponectin concentrations 55 urine NGAL 55 APTIVUS r 55 fasting serum 55 apnea hypopnea index 55 enoxaparin 55 density lipoprotein cholesterol 55 test OGTT 55 urinary albumin excretion 55 ULORIC 55 inflammatory biomarkers 54 mealtime insulin 54 ADAS cog 54 mm Hg diastolic 54 FOLFOX4 54 #.#mmol l [002] 54 postprandial glycemia 54 hyperuricemia 54 REYATAZ r arm 54 μg kg 54 Lantus R 54 NovoLog ® Mix 54 MMSE score 54 pulmonary capillary wedge 54 albuminuria 54 Lp PLA2 54 losartan 54 primary endpoint 54 Ramipril 54 dose atorvastatin 54 trough FEV1 54 lipid lowering medications 54 budesonide pMDI 54 ramipril 54 ACR# [002] 54 urate levels 54 SUVmax 54 Visual acuity 54 antihypertensive medication 54 #mg BID [003] 54 telmisartan 54 hyperphenylalaninemia HPA due 54 mg d 54 lymphocyte counts 54 clinically meaningful improvements 54 inhaled steroid 54 primary hypercholesterolemia 54 improves glycemic 54 RBP4 54 antibody titer 54 prespecified 54 KDOQI 54 elevated ALT 54 Hemoglobin 54 Victoza ® 54 μg dose 54 TAXUS Express Stent 54 Unified Parkinson Disease 54 NSTE ACS 54 plus MTX 54 overt nephropathy 54 concomitant medications 54 low dose Iluvien 54 prehypertension 54 albumin creatinine ratio 54 μg L 54 glycemic variability 54 subcutaneous insulin 54 mIU L 54 Median PFS 54 PREZISTA r 54 sd = 54 UPDRS scores 54 ACE inhibitor ramipril 54 achieved ACR# 54 #OHD levels 54 elevated triglyceride levels 54 ADCS ADL 54 thyroid stimulating hormone 54 ADAS Cog 54 statin therapy 54 atazanavir ritonavir 54 insulin degludec 54 serum TSH 54 comparator arm 54 triglyceride concentration 54 Hemoglobin A1c HbA1c 54 serum retinol 54 antibody titers 54 extrapyramidal symptoms 54 plus methotrexate 54 postprandial blood glucose 54 Prostate Specific Antigen 54 endoscopic remission 54 p = #.# [002] 54 A1Cs 54 serum lipid 54 undetectable HBV DNA 54 amlodipine 54 liver enzyme 54 + PH# 54 basal insulin 54 diastolic pressure 54 -#.# ± [002] 54 HSCT 54 dose cytarabine 54 lispro alone 54 PSA velocity 54 diabetes mellitus 54 PCWP 54 mcg Albuferon 54 fasting triglycerides 54 lanthanum carbonate 54 SpO 2 54 postprandial glucose PPG 54 DCCT 54 glycemic 54 mg ustekinumab 54 laboratory abnormalities 54 Hematocrit 54 PREZISTA r arm 54 PANSS 54 p = 54 g dl 54 canakinumab 54 specific antigen PSA 54 CYP#C# [001] 54 antihypertensive agents 54 recurrent VTE 54 -#.# mmol L 54 International Prostate Symptom 54 CsA 54 RBP4 levels 54 transferrin saturation 54 International Normalized Ratio 54 SHBG levels 54 eosinophil count 54 epoetin alfa 54 mcg BID 53 nmol L. 53 seroprotection 53 virological suppression 53 QTc prolongation 53 statistical significance 53 febuxostat 53 lixisenatide 53 lumbar spine bone 53 sulphonylurea 53 hemoglobin Hb 53 lopinavir ritonavir 53 homocysteine levels 53 intensive statin therapy 53 serum ferritin 53 nonfatal MI 53 intraocular pressure 53 Fasting plasma glucose 53 Triglyceride levels 53 apo B 53 serum cortisol 53 mineral density 53 ezetimibe simvastatin 53 beta blocker therapy 53 troponin 53 systolic pressure 53 teriflunomide 53 dosage regimens 53 montelukast 53 residual platelet reactivity 53 hip BMD 53 SCr 53 NNRTI resistance 53 Viral load 53 % CI #.#-#.# [003] 53 UPDRS 53 tacrolimus 53 ABC/3TC 53 HDL cholesterol 53 CD4 cell 53 KOMBIGLYZE XR 53 CIMZIA ™ 53 death reinfarction 53 tapentadol ER 53 viral suppression 53 paraprotein 53 kidney function 53 postintervention 53 atheroma volume 53 NIHSS 53 baseline serum creatinine 53 prospectively defined 53 EpCAM expression 53 disease progression 53 ApoB 53 evaluable subjects 53 symptomatic VTE 53 % Confidence Interval 53 DAPT 53 EDSS 53 abacavir lamivudine 53 clopidogrel 53 1c HbA 1c 53 prediabetes 53 LDL lowering 53 lowest tertile 53 urinary N telopeptide 53 transaminase levels 53 pegylated interferon alfa 53 Apidra R 53 estimated glomerular filtration 53 QTc 53 non inferiority 53 macrovascular disease 53 hypoglycaemia 53 degarelix 53 STRIDE PD 53 serum LDL cholesterol 53 LV dysfunction 53 NYHA class 53 gout flares 53 serum potassium levels 53 nocturnal hypoglycaemia 53 insulin sensitivity 53 levosimendan 53 carotid IMT 53 ZOMIG Nasal Spray 53 baseline FEV 53 low density lipoprotein 53 #mg dose [003] 53 everolimus eluting stents 53 serum albumin 53 lipid lowering agents 53 sulphonylureas 53 Index CDAI score 53 ARIXTRA 53 teriparatide 53 pyridostigmine 53 AZOR 53 DASH diet 53 QTc intervals 53 abacavir 53 IRLS score 53 μmol l 53 monotherapy 53 Welchol 53 serum clusterin levels 53 ezetimibe 53 aspartate aminotransferase 53 postoperative mortality 53 renal function 53 cardiorespiratory fitness 53 oral antidiabetic 53 endometrial thickness 53 adefovir 53 Blood Glucose 53 tamsulosin 53 plasma concentrations 53 sinus rhythm 53 #μg [002] 53 ruboxistaurin 53 #mg dose [002] 53 blood glucose concentrations 53 asthma exacerbations 53 liver enzymes ALT 53 aminotransferases 53 lipid lowering drugs 53 Serum creatinine 53 Cardiovascular Risk 53 lopinavir r arm 53 elevated triglycerides 53 mg QD 53 gm dl 53 ALLHAT 53 glycaemia 53 Expanded Disability Status 53 fluvastatin 53 bronchial hyperresponsiveness 53 Technosphere Insulin 53 transaminases 53 treat NNT 53 mTSS 53 bone resorption 53 serum folate 53 YMRS 53 secondary efficacy endpoint 53 placebo dexamethasone 53 post prandial glucose 53 rapid virological response 53 systemic embolism 53 warfarin 53 ACR# responses 53 candesartan cilexetil 53 hemoglobin 53 Median survival 53 mIU ml 53 hypoglycemic episodes 53 avosentan 53 vertebral fracture 53 hemoglobin A1C HbA1C 53 periprocedural 53 copies ml 53 gastric pH 53 virologic suppression 53 nmol l 53 abatacept 53 plasma triglycerides 53 F2 isoprostanes 53 CIMZIA TM 53 dyslipidaemia 53 nondiabetic 53 acute STEMI 53 exacerbations 53 #mg dose [001] 53 diameter stenosis 53 octreotide LAR 53 antigen PSA 53 Solid Tumors criteria 53 cerebrovascular events 53 detectable HCV RNA 52 viral kinetics 52 COPAXONE R 52 titrated glipizide plus 52 flow mediated dilation 52 plasma renin activity 52 #mg/day [002] 52 macrovascular 52 LDL HDL 52 SCIg 52 placebo fluoxetine 52 ibandronate 52 peg IFN 52 IFN beta 52 thiazide diuretics 52 infarct size 52 ALT elevations 52 severe renal impairment 52 Severity Index PASI 52 GFR 52 angiotensin converting enzyme inhibitors 52 HBeAg 52 lymphocyte count 52 Kaplan Meier analysis 52 moderate renal impairment 52 hours postdose 52 peak plasma concentrations 52 dose titration 52 adenoma recurrence 52 dose colchicine 52 risedronate 52 COPAXONE ® 52 efficacy endpoint 52 LANTUS ® 52 elevated troponin 52 imatinib therapy 52 IIIa inhibitors 52 nonresponders 52 perindopril 52 Secondary efficacy endpoints 52 Primary endpoints 52 oral rivaroxaban 52 infliximab 52 ADHD RS 52 Homocysteine 52 ETDRS 52 ARCOXIA 52 DAS# remission 52 diabetes mellitus DM 52 3mg 52 carotid stenosis 52 mL/min/#.# m2 52 systolic dysfunction 52 Lupuzor ™ 52 cTnT 52 elevated homocysteine 52 plus ribavirin 52 pulmonary exacerbations 52 esomeprazole 52 clodronate 52 timepoint 52 eptifibatide 52 deferasirox 52 hypercholesterolaemia 52 virological failure 52 carvedilol 52 methotrexate monotherapy 52 platelet counts 52 Ejection Fraction 52 anemia hemoglobin 52 olanzapine 52 NNT = 52 urinary excretion 52 μg dl 52 acarbose 52 oral antidiabetic agents 52 Insulin PH# 52 serum selenium 52 serum homocysteine 52 BARACLUDE 52 Ishak fibrosis score 52 Non inferiority 52 biochemical relapse 52 TDF FTC 52 p = #.# [003] 52 Liraglutide 52 IELT 52 HBeAg negative patients 52 primary efficacy endpoints 52 index BMI 52 urinary oxalate 52 mucosal healing 52 timepoints 52 JANUMET 52 ivabradine 52 IDDM 52 mg simvastatin 52 hemodialysis patients 52 posttreatment 52 #.#/#.# mm Hg [003] 52 doxorubicin docetaxel 52 serum aminotransferase levels 52 colorectal adenoma 52 Telmisartan 52 TC HDL 52 FOSRENOL ® 52 CANCIDAS 52 biochemical recurrence 52 NovoRapid 52 Baseline characteristics 52 TAXUS Stent 52 mg Lucentis 52 bosentan 52 Index CDAI 52 ximelagatran 52 glucose tolerance 52 pegylated interferon alfa 2b 52 FeNO 52 Pred Forte 52 rapid virologic response 52 elevated LDH 52 serum uric acid sUA 52 neutrophil count 52 TMC# r 52 salmeterol fluticasone 52 plasma uric acid 52 intraocular pressure IOP 52 periprocedural MI 52 AST ALT 52 SGOT 52 troponins 52 idraparinux 52 treatment emergent AEs 52 rosuvastatin #mg 52 ABPM 52 adjunctive placebo 52 nmol liter 52 strontium ranelate 52 isoprostane 52 tacrolimus ointment 52 CSBMs 52 Cystatin C 52 lipid abnormalities 52 EDARBI 52 ACTOplus met 52 HBsAg 52 experienced virologic failure 52 postdose 52 cytogenetic response 52 subclinical hyperthyroidism 52 thyrotropin levels 52 Durezol 52 elevated CRP 52 HER2 expression 52 tipranavir ritonavir 52 nonfasting triglycerides 52 mcg dose 52 Alzheimer Disease Assessment 52 mg BID 52 echocardiographic parameters 52 Montgomery Åsberg Depression 52 antidiabetic medication 52 CC genotype 52 nonvertebral fractures 52 Levemir ® 52 viral loads 52 #mm Hg 52 TPV r 52 plasma urate 52 IU ml 52 darunavir 52 odanacatib 52 plasma folate 52 HDL triglycerides 52 Levemir 52 SVR# 52 budesonide formoterol 52 alteplase 52 glycated albumin 52 RE LY ® 52 trials RCTs 52 P = .# 52 Sitagliptin 52 serum BDNF 52 #.#/#.# mm Hg [001] 52 DLQI 52 CNS LS 52 TZDs 52 aliskiren 52 hypogonadal men 52 CVD mortality 52 Tiotropium 52 Lipid Profile 52 NATRECOR ® 52 IOP lowering 52 Complications Trial 52 prehypertensive 52 APTIVUS 52 confirmed CCyR 52 intramuscular dose 52 serum triglyceride 52 LS BMD 52 LEXIVA 52 clinically meaningful reductions 52 mycophenolate mofetil 52 Tipranavir 52 #.#/#.# mm Hg [002] 52 mesalamine granules 52 DAS# scores 52 airway responsiveness 51 non fasting triglycerides 51 seropositive patients 51 coronary revascularization 51 mg BID dose 51 Pegasys ® 51 elevated fasting glucose 51 epoetin 51 vicriviroc 51 lipoprotein levels 51 azacitidine 51 platelet aggregation 51 SYMBICORT 51 serum sodium levels 51 CTAP# Capsules 51 Rating Scale MADRS 51 dalteparin 51 IgG 51 mmol liter 51 cardiometabolic risk 51 serum leptin 51 FOLPI 51 mitoxantrone 51 ziprasidone 51 adalimumab Humira 51 protein excretion

Back to home page